{"id":20044,"date":"2026-08-22T22:31:53","date_gmt":"2026-08-22T22:31:53","guid":{"rendered":"https:\/\/in-greece.com\/index.php\/2026\/08\/22\/could-glp-1-drugs-help-prevent-cancer\/"},"modified":"2026-08-22T22:31:53","modified_gmt":"2026-08-22T22:31:53","slug":"could-glp-1-drugs-help-prevent-cancer","status":"publish","type":"post","link":"https:\/\/in-greece.com\/index.php\/2026\/08\/22\/could-glp-1-drugs-help-prevent-cancer\/","title":{"rendered":"Could GLP-1 Drugs Help Prevent Cancer?"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div data-first=\"S\">\n<h3>Studies link GLP-1 drugs to lower rates of several obesity-related cancers, but researchers say the evidence does not yet prove cancer prevention<\/h3>\n<p>Could a class of drugs originally developed to treat diabetes and later transformed into a blockbuster treatment for weight loss offer another, very different benefit?<\/p>\n<p>Researchers are now examining that possibility as growing evidence suggests that GLP-1 drugs, including semaglutide, may be associated with a lower risk of developing or progressing certain cancers.<\/p>\n<p><em><span style=\"text-decoration: underline;\">Growing body of evidence<\/span><\/em><\/p>\n<p>The issue has attracted significant attention in cancer research. At the annual meeting of the American Society of Clinical Oncology (ASCO), researchers presented new data linking GLP-1 treatments to lower rates of some cancers, a reduced likelihood of metastasis and improved survival among some patients.<\/p>\n<p>A 2024 study involving more than 1.6 million people with type 2 diabetes found lower rates of 10 of 13 obesity-related cancers among people taking GLP-1 drugs compared with those taking insulin.<\/p>\n<p><em><span style=\"text-decoration: underline;\">Study involving 87,000 adults<\/span><\/em><\/p>\n<p>A year later, another study involving about 87,000 adults found that people who started GLP-1 treatment had an approximately 17% lower overall incidence of cancer.<\/p>\n<p>The largest reductions involved endometrial cancer, ovarian cancer and meningioma, a type of brain tumour.<\/p>\n<p><em><span style=\"text-decoration: underline;\">Scientists call for more evidence<\/span><\/em><\/p>\n<p>The findings have generated considerable interest, but researchers stress that they do not yet establish that GLP-1 drugs themselves prevent cancer.<\/p>\n<p>Ziyad Al-Aly, a physician and clinical epidemiologist at Washington University in St. Louis, has warned that public headlines have moved faster than the science.<\/p>\n<p>The fact that studies find a lower cancer risk among GLP-1 users does not automatically mean that the drugs caused that reduction.<\/p>\n<p><em><span style=\"text-decoration: underline;\">The challenge of observational studies<\/span><\/em><\/p>\n<p>Researchers face a major challenge because most studies conducted so far have been observational. They compare people taking GLP-1 drugs with people who do not take them, but the two groups may differ in important ways from the outset.<\/p>\n<p>People who have access to these medications, for example, may receive more regular medical care, have better access to healthcare or follow different lifestyles.<\/p>\n<p>Al-Aly also points out that cancer generally takes years to develop. When a study records a striking reduction in cancer risk soon after people begin treatment, researchers cannot easily determine whether the drugs produced a genuine anti-cancer effect or whether the result reflects characteristics shared by the people who started taking them.<\/p>\n<p><em><span style=\"text-decoration: underline;\">A revolution in obesity treatment<\/span><\/em><\/p>\n<p>These questions explain why researchers continue to invest in larger and longer-term studies.<\/p>\n<p>\u201cThere is no doubt that GLP-1 drugs, such as semaglutide and liraglutide, as well as newer GLP-1\/GIP drugs such as tirzepatide, have revolutionised the treatment of obesity,\u201d says Theodora Psaltopoulou, a physician and professor of Therapeutic Epidemiology and Preventive Medicine at the National and Kapodistrian University of Athens.<\/p>\n<p>\u201cWhen it comes to cancer, however, research is still ongoing,\u201d she stresses.<\/p>\n<p><strong><em>Four key questions remain<\/em><\/strong><\/p>\n<p>Psaltopoulou highlights four major questions that researchers still need to answer.<\/p>\n<p><span style=\"text-decoration: underline;\"><em>1. Can GLP-1 drugs cause cancer?<\/em><\/span><\/p>\n<p>Current evidence offers some reassurance.<\/p>\n<p>Large meta-analyses have not found an overall increase in cancer risk among people taking GLP-1 drugs.<\/p>\n<p><span style=\"text-decoration: underline;\"><em>2. Could GLP-1 drugs protect against some cancers?<\/em><\/span><\/p>\n<p>Researchers have found indications that the drugs could offer protection against certain cancers, although that effect may not apply equally across the population.<\/p>\n<p>Randomised clinical trials and their meta-analyses suggest that a protective effect may exist for some cancers, but researchers do not yet have enough evidence to describe GLP-1 drugs as proven cancer-prevention treatments.<\/p>\n<p><span style=\"text-decoration: underline;\"><em>3. Could the drugs improve outcomes for people who already have cancer?<\/em><\/span><\/p>\n<p>This represents another major area of research.<\/p>\n<p>Scientists are investigating whether GLP-1 drugs could improve outcomes during cancer treatment, including alongside immunotherapy, or after treatment ends.<\/p>\n<p>Several biological mechanisms could potentially explain such an effect. These include reductions in obesity, hyperinsulinemia and chronic inflammation, as well as possible direct effects on cancer and immune cells.<\/p>\n<p>Clinical trials are already examining these possibilities. Researchers also need to determine whether the effects depend on the dose or duration of treatment.<\/p>\n<p><span style=\"text-decoration: underline;\"><em>4. How reliable are the studies?<\/em><\/span><\/p>\n<p>The type of study matters greatly when researchers assess the evidence.<\/p>\n<p>Scientists must distinguish between observational studies, randomised clinical trials and real-world data from electronic health records, such as those available in the United States and Scandinavian countries.<\/p>\n<p>These different approaches can produce different levels of evidence and help researchers determine whether an apparent association represents a genuine causal effect.<\/p>\n<p><em><span style=\"text-decoration: underline;\">More research needed<\/span><\/em><\/p>\n<p>For now, researchers say the evidence remains promising but incomplete.<\/p>\n<p>GLP-1 drugs have clearly transformed the treatment of obesity, but their potential role in cancer prevention or treatment requires further investigation.<\/p>\n<p>\u201cMore analyses and publications\u201d are needed before scientists can draw firm conclusions, Psaltopoulou says.<\/p>\n<p>Until then, GLP-1 drugs should remain prescribed according to their approved indications and current clinical guidelines, with appropriate medical supervision.<\/p>\n<h3\/>\n<ol>\n<li\/>\n<\/ol>\n<footer class=\"article-tags entry-footer\">\n<\/footer>\n<div class=\"category_container author-information\">\n<div class=\"inner\">\n<section id=\"authorpage\" class=\"authorpage\">\n\t\t\t\t<img loading=\"lazy\" alt=\"\" src=\"https:\/\/secure.gravatar.com\/avatar\/74a7af42a3ee68b1eb9b880b91e3e713144e269e50db87b04a35501c8e1351f8?s=164&amp;r=g\" srcset=\"https:\/\/secure.gravatar.com\/avatar\/74a7af42a3ee68b1eb9b880b91e3e713144e269e50db87b04a35501c8e1351f8?s=328&amp;r=g 2x\" class=\"avatar avatar-164 photo lazyload\" height=\"164\" width=\"164\" decoding=\"async\"\/>\t<\/p>\n<div class=\"author-content\">\n<h5>Kosta Papadopoulos<\/h5>\n<p>Kosta Papadopoulos is an editor at Greek City Times, covering Greek and international news, travel, sport, and entertainment.<\/p>\n<\/p><\/div>\n<\/section><\/div>\n<\/div><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/greekcitytimes.com\/2026\/08\/23\/could-glp-1-drugs-help-prevent-cancer\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Studies link GLP-1 drugs to lower rates of several obesity-related cancers, but researchers say the evidence does not yet prove cancer prevention Could a class of drugs originally developed to treat diabetes and later transformed into a blockbuster treatment for weight loss offer another, very different benefit? Researchers are now examining that possibility as growing &#8230; <\/p>\n<p class=\"read-more-container\"><a title=\"Could GLP-1 Drugs Help Prevent Cancer?\" class=\"read-more button\" href=\"https:\/\/in-greece.com\/index.php\/2026\/08\/22\/could-glp-1-drugs-help-prevent-cancer\/#more-20044\" aria-label=\"Read more about Could GLP-1 Drugs Help Prevent Cancer?\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":20045,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"iawp_total_views":0,"fifu_image_url":"https:\/\/greekcitytimes.com\/wp-content\/uploads\/2026\/08\/Screenshot-2026-08-23-at-7.20.49-am.jpg","fifu_image_alt":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-20044","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","no-featured-image-padding"],"_links":{"self":[{"href":"https:\/\/in-greece.com\/index.php\/wp-json\/wp\/v2\/posts\/20044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/in-greece.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/in-greece.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/in-greece.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/in-greece.com\/index.php\/wp-json\/wp\/v2\/comments?post=20044"}],"version-history":[{"count":0,"href":"https:\/\/in-greece.com\/index.php\/wp-json\/wp\/v2\/posts\/20044\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/in-greece.com\/index.php\/wp-json\/wp\/v2\/media\/20045"}],"wp:attachment":[{"href":"https:\/\/in-greece.com\/index.php\/wp-json\/wp\/v2\/media?parent=20044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/in-greece.com\/index.php\/wp-json\/wp\/v2\/categories?post=20044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/in-greece.com\/index.php\/wp-json\/wp\/v2\/tags?post=20044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}